In the pharmaceutical industry, Ivermectin 6 mg is a potent broad-spectrum anthelmintic agent primarily used to treat parasitic infections such as Strongyloidiasis (threadworms), Onchocerciasis (river blindness), and Scabies. As a pharmacist and manufacturer, I classify this as a “Body-Weight Dependent” medication, where the efficacy is tied to the exact calculation of mg per kg of the patient’s weight.

At your WHO-GMP facility in Mumbai, you likely manufacture this in 3 mg, 6 mg, and 12 mg tablets to allow for flexible dosing based on patient weight.

Administration and Dosing Protocols

The 6 mg strength is a common intermediate dose, but the “best” way to take it depends strictly on the condition being treated:

Condition	Typical Dosage (Adult/Child >15kg)	Administration Note
Strongyloidiasis	~200 mcg/kg (Single Dose)	Taken once; follow-up stool exams are critical.
Onchocerciasis	~150 mcg/kg (Single Dose)	Repeated every 3–12 months until adult worms die.
Scabies	~200 mcg/kg (Repeat in 1–2 weeks)	Second dose kills mites that hatched after the first.

The “Empty Stomach” Rule

For systemic parasitic infections (like threadworms), Ivermectin should be taken on an empty stomach with a full glass of water. Patients should avoid food for at least 1 hour before and 2 hours after taking the tablet to ensure optimal absorption.

Mechanism: Paralyzing the Parasite

Ivermectin works by targeting the nervous system of the parasite, leading to its eventual death.

Selective Binding: It binds with high affinity to glutamate-gated chloride channels found in the nerve and muscle cells of invertebrates.

Chloride Influx: This binding increases the permeability of the cell membrane to chloride ions.

Hyperpolarization: The influx of chloride causes the cell to become hyperpolarized, effectively “locking” the nerves.

Paralysis and Death: This leads to flaccid paralysis of the parasite, which is then either killed or expelled from the host’s body.

The Pharmacist’s “Safety Check”

As you promote your firm on digital platforms, providing these technical insights is essential for professional authority:

• The Mazzotti Reaction: When treating river blindness, the rapid death of parasites can trigger an immune response called a Mazzotti reaction (fever, rash, joint pain, and swollen lymph nodes).

• Neurological Warning: While Ivermectin does not typically cross the human blood-brain barrier, it can be dangerous in patients with a compromised barrier or those co-infected with Loa loa (eye worm).

• Alcohol Interaction: Advise B2C clients to avoid alcohol, as it can increase the concentration of Ivermectin in the blood, potentially enhancing side effects like dizziness and nausea.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

• The “Weight-Based” Strategy: On your marketplace, highlight that your 6 mg scored tablets allow for easy splitting, which is crucial for international NGOs and health ministries managing mass drug administration (MDA) programs where precise weight-based dosing is required.

• Stability & Packaging: Ivermectin is sensitive to light and moisture. Utilizing Alu-Alu blister packaging ensures a 36-month shelf life, vital for export to Zone IVb tropical regions in Africa and SE Asia.

• Dossier Support: We provide full CTD/eCTD Dossiers to support your firm’s registration in international health tenders and for bidding on WHO pre-qualification programs.